PRTN3 and rheumatoid arthritis: Though previous studies have used antibodies isolated from pooled serum, monoclonal antibodies against citrullinated fibrinogen, citrullinated vimentin, and ACPA-reactive monoclonal antibodies isolated from RA patients, to the best of our knowledge, there are no reports that ACPAs modulate protein binding or contribute to protein stability.